Realm Therapeutics plc American Depositary Shares
RLM
RLM was delisted on the 30th of July, 2019.
8 hedge funds and large institutions have $9.64M invested in Realm Therapeutics plc American Depositary Shares in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
276% more capital invested
Capital invested by funds: $2.56M → $9.64M (+$7.07M)
100% more funds holding
Funds holding: 4 → 8 (+4)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HSBC Holdings
London,
United Kingdom
|
+$1.49M |
| 2 |
A
Abingworth
London,
United Kingdom
|
+$716K |
| 3 |
BI
BVF Inc
San Francisco,
California
|
+$707K |
| 4 |
FIA
FNY Investment Advisers
New York
|
+$98.9K |
| 5 |
IG
ING Group
Amsterdam,
Netherlands
|
+$83K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1.05K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
O
1
OrbiMed
New York
| $3.93M | – | – | – |
|
|
BI
2
BVF Inc
San Francisco,
California
| $2.41M | +$707K | +252,023 | +70% |
|
|
3
HSBC Holdings
London,
United Kingdom
| $2.04M | +$1.49M | +530,550 | New |
|
|
A
4
Abingworth
London,
United Kingdom
| $988K | +$716K | +255,371 | New |
|
|
FIA
5
FNY Investment Advisers
New York
| $138K | +$98.9K | +35,242 | New |
|
|
IG
6
ING Group
Amsterdam,
Netherlands
| $116K | +$83K | +29,600 | New |
|
|
WF
7
WealthTrust Fairport
Cleveland,
Ohio
| $9K | – | – | – |
|
|
8
UBS Group
Zurich,
Switzerland
| $1K | -$1.05K | -374 | -68% |
|
RLM Hedge Fund Activity: Q1 2019 in Review
8 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Realm Therapeutics plc American Depositary Shares (RLM) for Q1 2019, worth a combined $9.64M — up 276% from $2.56M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new RLM positions and 0 closed out — a net gain of 4 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was HSBC Holdings, opening a new position worth an estimated $1.49M. The largest seller was UBS Group, cutting an estimated $1.05K.
- 8 institutional investors held Realm Therapeutics plc American Depositary Shares (RLM) as of Q1 2019, up from 4 in Q4 2018.
- Funds reported $9.64M of Realm Therapeutics plc American Depositary Shares stock for Q1 2019, up 276% quarter-over-quarter.
- 4 funds opened new Realm Therapeutics plc American Depositary Shares positions in Q1 2019 and 0 closed out, a net change of +4 holders.
- The largest Realm Therapeutics plc American Depositary Shares buyer in Q1 2019 was HSBC Holdings, an estimated $1.49M added.
- The largest Realm Therapeutics plc American Depositary Shares seller in Q1 2019 was UBS Group, an estimated $1.05K sold.
Based on aggregated 13F filings for Q1 2019.